About Index Trending news
Analyze
Top 50 Pricing
Cytodyn

Cytodyn

Work at Cytodyn? Add yourself to this profile

Cytodyn

CytoDyn is a biotechnology company focused on the development of new therapiesto combat infections with immune deficiency viruses.

Elsewhere

Alexa global traffic share

Twitter followers

11 May 2016
$4,300,000
Venture capital (Series Undisclosed)

SEC FORM D

sec
23 Feb 2016
$33,270,000
Post-IPO equity

SEC FORM D/A

sec